Aehr Test Systems, Inc. designs, manufactures, and sells systems for testing, burning-in, and monitoring semiconductor devices at the wafer level, singulated die, or packaged part form. The company's core business centers on advanced burn-in testing equipment, particularly for high-power semiconductors like silicon carbide (SiC) power devices used in electric vehicles (EVs) and power management, as well as emerging applications in AI processors and data centers. In the competitive semiconductor equipment industry, Aehr maintains niche leadership in wafer-level test and burn-in solutions, setting itself apart with its FOX-XP and FOX-CP systems tailored for next-generation chips. From what I see, this positioning in high-growth areas like AI infrastructure and EVs has contributed significantly to the recent stock price strength, as demand surges for reliable testing of complex, high-reliability chips.
Over the last 30 days, AEHR stock rose from a closing price of approximately $36.31 to $80.85, marking a +123% gain. The movement proved highly volatile and trend-driven, featuring sharp spikes after key announcements, including multi-day surges exceeding 50% in a single week.
In the past quarter, the stock advanced from around $28.81 to $80.85, delivering a +181% increase. This performance showed a steady uptrend with bouts of volatility and accelerated gains in the final month tied to AI catalysts. It clearly outpaced broader market trends, highlighting sector-specific momentum.
The main catalyst came from a record $41 million production order from a leading hyperscale AI customer for package-level burn-in testing of custom AI processor application-specific integrated circuits (ASICs), which sparked a 15%+ single-day surge. This built on second-half bookings surpassing $92 million, pointing to robust demand. Q3 fiscal earnings reported on April 7 showed revenue of $10.3 million, missing expectations, but EPS beat at -$0.05 alongside $37 million in bookings from AI and data center demand, which lifted sentiment. I also reviewed analyst notes emphasizing momentum, including golden cross technical patterns and outperformance against computer peers. Sector tailwinds from AI chip testing enthusiasm added further lift. One thing that stands out is how I cross-checked these trends using Tickeron’s AI Trend Prediction Engine, which aligned with the bullish signals.
The quarter's +181% rally was driven by sustained AI and data center semiconductor demand, with Aehr securing multiple FOX XP system deals connected to infrastructure growth. Fiscal Q2 results in early January reinstated guidance amid better AI processor visibility, despite softer revenue, establishing a bullish outlook. Broader developments, like the semiconductor rally sparked by NVDA and AVGO, heightened exposure. Institutional interest rose alongside high trading volumes, while favorable macro conditions for tech spending and lower rates bolstered high-beta (2.29) stocks like AEHR. In my view, cumulative AI orders had the most substantial impact here.
One resource I've found valuable for navigating stocks like AEHR is Tickeron’s Trending AI Robots page, which highlights top-performing AI trading bots from its library of hundreds of algorithms trading thousands of tickers across markets. These bots are selected based on recent metrics like win rate, profit factor, and Sharpe ratio, covering strategies from short-term scalping to long-term trend following. Each includes details on timeframe, risk level, historical performance, and assets, making it straightforward to find ones that fit volatile, AI-driven plays. I check this page regularly to see how automated strategies are handling similar trends.
Looking ahead, I'm watching fiscal Q4 earnings around July 2026 for insights into AI order fulfillment and backlog conversion. Ongoing hyperscale customer wins and silicon photonics progress could keep the momentum going. Broader trends in AI data centers and EV power semis will remain critical, as will macro factors like interest rates affecting tech capex. On the risk side, supply chain disruptions or revenue shortfalls bear monitoring, while new partnerships could spark further upside. This is important because it shapes the path forward in this fast-moving sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
AEHR saw its Momentum Indicator move above the 0 level on September 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 77 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on September 18, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 30 of 37 cases over the following month. The odds of a continued upward trend are 81%.
AEHR moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +7.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Aroon Indicator entered an Uptrend today. In 201 of 230 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.663) is normal, around the industry mean (8.078). P/E Ratio (19.449) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment